Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Oral rhIL-11 improves mucosal inflammation in chronic colitis model

Feb. 25, 2004

Preliminary efficacy results of a Zadaxin triple therapy in hepatitis C

Feb. 24, 2004

Clinical trial of ANA-971, oral prodrug of isatoribine

Feb. 23, 2004

Second phase III safety study of SPI-0211 confirms earlier positive results

Feb. 23, 2004

New anti-HCV agents described by researchers at K.U. Leuven and Gilead

Feb. 23, 2004

Small-molecule CFTR inhibitor for prevention of toxin-induced secretory diarrhea

Feb. 23, 2004

PEG-Intron Redipen gets U.S. launch

Feb. 19, 2004

Axxima discovers casein kinase CKI inhibitors with utility in HCV infection

Feb. 18, 2004

Toll-like receptor 9 mediates beneficial effects of probiotics in vivo

Feb. 18, 2004

Merck & Isis collaboration yields novel HCV NS5B inhibitors

Feb. 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...